CAS: 14975-30-5; H-Arg-Nh2.2Hcl

该化合物是一种经化学修正的L-arginine衍生物,其特点是在碳酸乙烯终点和两个盐盐的氨化物组,这一修改增强了其在水溶液中的溶解性,使之适合生化和制药用途.化合物保留了半硝基苯的功能性腺组,这对与一氧化二氮合成酶(NOS)和丙酸酯(rginaase)等生物目标的相互作用至关重要.在受控制的条件下,其高纯度和稳定性确保了可靠的研究性能,包括酶研究,peptide合成和细胞培养实验.二氢氯化物形式也有助于在配制研究中精确地施用.

结构式图片

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-8227571-B2
    优先权日:2007-12-11
    标题 :Insulinotropic peptide synthesis using solid and solution phase combination techniques
    发明人:CHEN LIN; HAN YEUN-KWEI; ROBERTS CHRISTOPHER R
    权利人:CHEN LIN; HAN YEUN-KWEI; ROBERTS CHRISTOPHER R; ROCHE PALO ALTO LLC
    摘要:The present invention relates to the preparation of insulinotropic peptides that are synthesized using a solid and solution phase (“hybrid†) approach. Generally, the approach includes synthesizing three different peptide intermediate fragments using solid phase chemistry. Solution phase chemistry is then used to add additional amino acid material to the third fragment which is then coupled to the second fragment and then the first fragment in solution. Alternatively, a different second fragment is coupled to the first fragment in the solid phase. Then, solution phase chemistry is then used to add additional amino acid material to a different third fragment. Subsequently, this different third fragment is coupled to the coupled first and different second fragment in the solution phase. The use of a pseudoproline in one of the fragments eases solid phase synthesis of that fragment and also eases subsequent solution phase coupling of this fragment to the other fragments. The present invention is very useful for forming insulinotropic peptides such as GLP-1(7-36) and its natural and non-natural counteparts.

    专利号:WO-2025042853-A1
    优先权日:2023-08-18
    标 题 :Compositions and methods for prophylaxis and/or treatment of alpha synuclein proteinopenia in parkinson's and other diseases
    发明人:LEE JIN HYUNG; AHMED KARIEM E
    权利人:LVIS REGAIN LP
    摘要:Material compositions and/or methods useful for the prophylaxis and/or treatment of a-syn protein depletion (proteinopenia) are provided, including material compositions that retain native function of a-syn protein while limiting and/or preventing amyloid formation and/or aggregation of said protein. Material compositions and formulations for enhancing protein solubility, stability, circulation time, receptor interaction, brain penetrance, CSF halflife, and for facilitating peptide/protein synthesis and purification are also provided.

    专利号:US-2010292435-A1
    优先权日:2009-05-01
    标题 :Insulinotropic peptide synthesis using solid and solution phase combination techniques
    发明人:CHEN LIN; HAN YEUN-KWEI; ROBERTS CHRISTOPHER R
    权利人:CHEN LIN; HAN YEUN-KWEI; ROBERTS CHRISTOPHER R
    摘要:The present invention relates to the preparation of insulinotropic peptides that are synthesized using a solid and solution phase (“hybrid†) approach. Generally, the approach includes synthesizing three different peptide intermediate fragments using solid phase chemistry. Solution phase chemistry is then used to couple the second fragment and the first fragment. Alternatively, a different second fragment is coupled to a first fragment in the solid phase. Then, solution phase chemistry is then used to add the third fragment, whereby the third fragment is coupled to the coupled first and second fragments in the solution phase. The present invention is very useful for forming insulinotropic peptides such as GLP-1(7-36) and its natural and non-natural counterparts.

    专利号:CN-103613642-A
    优先权日:2013-11-20
    标题:A liquid phase segmented synthesis method of hexapeptide
    成都悦康科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.yuekangtech.com
    电话: 0086 (28) 8669-1469👤
    📞成都悦康科技有限公司 ⚠️参考联系方式

    销售电话:0086 (28) 8669-1469
    邮箱:richard@yuekangtech.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s00706-017-2074-x
    摘要:Müller BJ, Mistlberger G, Klimant I. Insights in the determination of saxitoxin with fluorogenic crown ethers in water. Monatshefte für Chemie - Chemical Monthly. 2018 Jan 11;149(3):493–7. doi: 10.1007/s00706-017-2074-x.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知